INFLUENCE OF RENAL-FAILURE ON THE HEPATIC-CLEARANCE OF BUFURALOL IN MAN

被引：32

作者：

BALANT, L

FRANCIS, RJ

TOZER, TN

MARMY, A

TSCHOPP, JM

FABRE, J

机构：

[1] ROCHE PROD LTD,DEPT DRUG METAB,WELWYN GARDEN CTY AL7 3AY,HERTFORDSHIRE,ENGLAND

[2] UNIV CALIF SAN FRANCISCO,SCH PHARM,SAN FRANCISCO,CA 94143

来源：

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1980年 / 8卷 / 05期

关键词：

D O I：

10.1007/BF01059544

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：421 / 438

页数：18

共 14 条

[1]

BALANT L, 1978, PHARM ACTA HELV, V53, P307

[2]

BALANT L, 1976, SCHWEIZ MED WSCHR, V106, P1403

[3] LONG-TERM EFFECT OF PROPRANOLOL THERAPY ON RENAL-FUNCTION [J].

BAUER, JH ;

BROOKS, CS .

AMERICAN JOURNAL OF MEDICINE, 1979, 66 (03) :405-410

[4]

BIANCHETTI G, 1976, Clinical Pharmacokinetics, V1, P373, DOI 10.2165/00003088-197601050-00004

[5] DETERMINATION OF BUFURALOL AND ITS METABOLITES IN PLASMA BY MASS FRAGMENTOGRAPHY AND BY GAS-CHROMATOGRAPHY WITH ELECTRON-CAPTURE DETECTION [J].

FRANCIS, RJ ;

EAST, PB ;

MCLAREN, SJ ;

LARMAN, J .

BIOMEDICAL MASS SPECTROMETRY, 1976, 3 (06) :281-285

[6]

FRANCIS RJ, 1976, EUROP J DRUG METAB P, V2, P113

[7]

JOHNSSON G, 1976, Clinical Pharmacokinetics, V1, P233

[8]

LOWENTHAL DT, 1974, CLIN PHARMACOL THER, V16, P761

[9]

Pang K S, 1977, J Pharmacokinet Biopharm, V5, P625, DOI 10.1007/BF01059688

[10] INCREASED PLASMA-PROTEIN BINDING OF PROPRANOLOL AND CHLORPROMAZINE MEDIATED BY DISEASE-INDUCED ELEVATIONS OF PLASMA ALPHA-1-ACID GLYCOPROTEIN [J].

PIAFSKY, KM ;

BORGA, O ;

ODARCEDERLOF, I ;

JOHANSSON, C ;

SJOQVIST, F .

NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (26) :1435-1439

← 1 2 →